6th Neuropsychiatric Drug Development Hilton Boston Back Bay, Boston
2023 is booming with novel psychiatric R AND D and the promise of precision medicine for neuropsychiatric patients. Pipelines are gaining momentum, with notable approvals on the horizon, as unmet needs in PTSD, bipolar, anxiety, schizophrenia, depression, and ADHD become greater and greater. There is, therefore, a huge deal of novel and promising research to be discussed this October at the 6th Neuropsychiatric Drug Development Summit.
With discovery, preclinical, translational, and clinical scientists from the likes of Biogen, Otsuka, AbbVie, Genentech, Lundbeck, Delix Therapeutics, Atai, Gilgamesh, and Cerevel Therapeutics, don’t miss the field’s favorite conference, specifically dedicated to biopharma’s most pressing challenges of de-risking the translational gap and advancing transformative neuropsychiatric candidates through the clinic.
⌛ Event Dates & Venue
💸 Website & Tickets
Go to Event WebsiteDrug Developer Pricing - Conference + 2 Workshops: USD 3597.00, Drug Developer Pricing - Conference + 1 Workshop: USD 3098.00, Drug Developer Pricing - Conference Only: USD 2599.00, Solution Provider Pricing - Conference + 2 Workshops: USD 5297.00, Solution Provider Pricing - Conference + 1 Workshop: USD 4548.00, Solution Provider Pricing - Conference Only: USD 3799.00
Advertisements